| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $29.85M | $27.04M | $23.76M | $21.80M | $22.50M |
| Operating Income | $69.97M | $128.43M | $104.15M | $184.65M | $191.42M |
| Interest Expense | – | – | $24.71M | $17.14M | $14.72M |
| Tax Expense | – | – | – | – | – |
| Net Income | $38.56M | $97.38M | $77.35M | $172.55M | $174.35M |
| EPS (basic) | 0.3000 | 0.8300 | 0.6100 | 1.3600 | 1.4400 |
| EPS (diluted) | 0.3000 | 0.8300 | 0.6100 | 1.3600 | 1.4400 |
| Shares (diluted) | $103.04M | $107.58M | $113.62M | $120.65M | $113.72M |